Dr Altamira - Sport Gen Z

Pharmabiz: Altamira Bio buys NIH license & CRADAs to develop ManNac for rare genetic disorders Fortress Biotech, Inc. announced that its subsidiary, Altamira Bio, acquired from New Zealand Pharmaceuticals Ltd (NZP), a license from the National Institutes of Health (NIH) and Cooperative Research ... Altamira Bio buys NIH license & CRADAs to develop ManNac for rare genetic disorders